Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Patrick Lin Biography and Net Worth

Insider of Processa Pharmaceuticals

Mr. Lin has over 20 years of financing and investing experience in the Biopharm Sector. He was Co-Founder and Chairman of the Board of Promet Therapeutics, LLC . He is Founder and Managing Partner of Primarius Capital, a family office that manages public and private investments focused on small capitalization companies. For 10 years prior to forming Primarius Capital, Mr. Lin worked at several Wall Street banking and brokerage firms including Robertson Stephens & Co., E*Offering, and Goldman Sachs & Co. Mr. Lin was Co-Founding Partner of E*Offering.

Mr. Lin received an MBA from Kellogg Graduate School of Management, a Master of Engineering Management, and a Bachelor of Science in Business Administration from the University of Southern California.

What is Patrick Lin's net worth?: The estimated net worth of Patrick Lin is at least $63,775.99 as of January 31st, 2024. Mr. Lin owns 25,978 shares of Processa Pharmaceuticals stock worth more than $63,776 as of April 25th. This net worth evaluation does not reflect any other assets that Mr. Lin may own. Additionally, Mr. Lin receives a salary of $117,150.00 as Insider at Processa Pharmaceuticals. Learn More about Patrick Lin's net worth.
How old is Patrick Lin?: Mr. Lin is currently 59 years old. There are 5 older executives and no younger executives at Processa Pharmaceuticals. The oldest executive at Processa Pharmaceuticals is Dr. David Young Ph.D., Pharm.D., Co-Founder, President of Research and Development & Director, who is 71 years old. Learn More on Patrick Lin's age.
What is Patrick Lin's salary?: As the Insider of Processa Pharmaceuticals, Inc., Mr. Lin earns $117,150.00 per year. There are 4 executives that earn more than Mr. Lin. The highest earning executive at Processa Pharmaceuticals is Mr. George K. Ng Esq., J.D., Chief Executive Officer, who commands a salary of $400,270.00 per year. Learn More on Patrick Lin's salary.
How do I contact Patrick Lin?: The corporate mailing address for Mr. Lin and other Processa Pharmaceuticals executives is 7380 COCA COLA DRIVE SUITE 106, HANOVER MD, 21076. Processa Pharmaceuticals can also be reached via phone at (443) 776-3133 and via email at [email protected]. Learn More on Patrick Lin's contact information.
Has Patrick Lin been buying or selling shares of Processa Pharmaceuticals?: Patrick Lin has not been actively trading shares of Processa Pharmaceuticals during the last ninety days. Most recently, on Wednesday, January 31st, Patrick Lin bought 2,500 shares of Processa Pharmaceuticals stock. The stock was acquired at an average cost of $2.37 per share, with a total value of $5,925.00. Following the completion of the transaction, the insider now directly owns 25,978 shares of the company's stock, valued at $61,567.86. Learn More on Patrick Lin's trading history.
Who are Processa Pharmaceuticals' active insiders?: Processa Pharmaceuticals' insider roster includes Robert Floyd (COO), Patrick Lin (Insider), James Stanker (CFO), Justin Yorke (Director), and David Young (CEO). Learn More on Processa Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Processa Pharmaceuticals?: During the last year, Processa Pharmaceuticals insiders bought shares 5 times. They purchased a total of 43,500 shares worth more than $137,895.00. The most recent insider tranaction occured on February, 7th when insider David Young bought 21,000 shares worth more than $51,450.00. Insiders at Processa Pharmaceuticals own 22.2% of the company. Learn More about insider trades at Processa Pharmaceuticals.
Information on this page was last updated on 2/7/2024.

Patrick Lin Insider Trading History at Processa Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/31/2024	Buy	2,500	$2.37	$5,925.00	25,978
5/17/2022	Buy	100	$31.80	$3,180.00	21,669
4/6/2022	Buy	60	$62.60	$3,756.00	21,569
12/14/2021	Buy	150	$80.00	$12,000.00
12/3/2021	Buy	175	$96.00	$16,800.00
8/26/2021	Buy	200	$120.40	$24,080.00	21,144

Patrick Lin Buying and Selling Activity at Processa Pharmaceuticals

Processa Pharmaceuticals Company Overview

Processa Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing the chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells. Its pipeline includes three Chemotherapy drugs, including Capecitabine, PCS6422 and capecitabine to treat metastatic colorectal, gastrointestinal, breast, pancreatic, and other cancers; Gemcitabine, PCS3117 to treat pancreatic, lung, ovarian, breast, and other cancers; and Irinotecan, PCS11T to treat lung, colorectal, gastrointestinal, pancreatic, and other cancers. Processa Pharmaceuticals, Inc. was incorporated in 2011 and is based in Hanover, Maryland.

Today's Range

Now: $2.46

$2.08

$2.68

50 Day Range

MA: $2.20

$1.52

$2.99

2 Week Range

Now: $2.46

$1.40

$18.00

Volume

74,482,246 shs

Average Volume

2,232,411 shs

Market Capitalization

$7.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.53

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!

From Priority Gold | Ad

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

Patrick Lin Biography and Net Worth

What is Patrick Lin's net worth?

How old is Patrick Lin?

What is Patrick Lin's salary?

How do I contact Patrick Lin?

Has Patrick Lin been buying or selling shares of Processa Pharmaceuticals?

Who are Processa Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Processa Pharmaceuticals?